Pratteln, 29.07.2021 – The CABB Group is strengthening its Exclusives & Specialties division with the appointment of Dr. Rajiv Grover, 52, on September 1, 2021. The proven sales expert with international management experience will be responsible for growing the existing key accounts and new customer business in this division. Dr. Rajiv Grover will be reporting directly to CEO Valerie Diele-Braun.
With Dr. Rajiv Grover taking over as the new Sales Head Exclusives & Specialties on September 1, 2021, the CABB Group is strengthening its team with a highly qualified new addition.
Dr. Grover can draw on many years of international management experience, most recently as Director Sales Key Account Management Pharma EMEA & LATAM with the Aenova Group, where he was responsible for global key accounts and new customer acquisition, as well as managing a team with operations in five countries. Prior to that, he held the position of Global Senior Sales Manager, Pharma API Generics, at Dolder AG, overseeing sales and procurement of active pharmaceutical ingredients.
At CABB, Dr. Grover will serve as Sales Head Exclusives & Specialties and assume responsibility for growing the existing key accounts and new customer acquisitions. He will be based at the Pratteln (CH) site. “Rajiv is an experienced international manager with an outstanding track record in sales,” CEO Valerie Diele-Braun commented. “With his extensive and diversified experience, as well as his engaging personality and structured approach, he will make an important contribution as part of CABB’s growth strategy.”
Dr. Grover, a father of two and a German citizen, also holds a doctorate in pharmacy.